Copyright Reports & Markets. All rights reserved.

Global Invasive Candidiasis Treatment Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Invasive Candidiasis Treatment Drug
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Invasive Candidiasis Treatment Drug by Type
    • 1.3.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type in 2022
    • 1.3.3 Azoles Drug
    • 1.3.4 Echinocandins Drug
    • 1.3.5 Allylamines Drug
    • 1.3.6 Polyenes Drug
    • 1.3.7 Others
  • 1.4 Global Invasive Candidiasis Treatment Drug Market by Application
    • 1.4.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Invasive Candidiasis Treatment Drug Market Size & Forecast
  • 1.6 Global Invasive Candidiasis Treatment Drug Market Size and Forecast by Region
    • 1.6.1 Global Invasive Candidiasis Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Invasive Candidiasis Treatment Drug Market Size by Region, (2018-2029)
    • 1.6.3 North America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
    • 1.6.6 South America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 GlaxoSmithKline
    • 2.1.1 GlaxoSmithKline Details
    • 2.1.2 GlaxoSmithKline Major Business
    • 2.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.1.4 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.2 Merck & Co., Inc
    • 2.2.1 Merck & Co., Inc Details
    • 2.2.2 Merck & Co., Inc Major Business
    • 2.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.2.4 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Merck & Co., Inc Recent Developments and Future Plans
  • 2.3 Pfizer Inc
    • 2.3.1 Pfizer Inc Details
    • 2.3.2 Pfizer Inc Major Business
    • 2.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.3.4 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Pfizer Inc Recent Developments and Future Plans
  • 2.4 Cidara Therapeutics, Inc
    • 2.4.1 Cidara Therapeutics, Inc Details
    • 2.4.2 Cidara Therapeutics, Inc Major Business
    • 2.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.4.4 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Cidara Therapeutics, Inc Recent Developments and Future Plans
  • 2.5 Astellas Pharma Inc
    • 2.5.1 Astellas Pharma Inc Details
    • 2.5.2 Astellas Pharma Inc Major Business
    • 2.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.5.4 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Astellas Pharma Inc Recent Developments and Future Plans
  • 2.6 Gilead Sciences, Inc
    • 2.6.1 Gilead Sciences, Inc Details
    • 2.6.2 Gilead Sciences, Inc Major Business
    • 2.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.6.4 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Gilead Sciences, Inc Recent Developments and Future Plans
  • 2.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
    • 2.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Details
    • 2.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
    • 2.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments and Future Plans
  • 2.8 Biosergen AB
    • 2.8.1 Biosergen AB Details
    • 2.8.2 Biosergen AB Major Business
    • 2.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.8.4 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Biosergen AB Recent Developments and Future Plans
  • 2.9 Matinas BioPharma Holdings, Inc
    • 2.9.1 Matinas BioPharma Holdings, Inc Details
    • 2.9.2 Matinas BioPharma Holdings, Inc Major Business
    • 2.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.9.4 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Matinas BioPharma Holdings, Inc Recent Developments and Future Plans
  • 2.10 Pulmocide Ltd
    • 2.10.1 Pulmocide Ltd Details
    • 2.10.2 Pulmocide Ltd Major Business
    • 2.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.10.4 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Pulmocide Ltd Recent Developments and Future Plans
  • 2.11 F2G Ltd
    • 2.11.1 F2G Ltd Details
    • 2.11.2 F2G Ltd Major Business
    • 2.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product and Solutions
    • 2.11.4 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 F2G Ltd Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Invasive Candidiasis Treatment Drug Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Invasive Candidiasis Treatment Drug by Company Revenue
    • 3.2.2 Top 3 Invasive Candidiasis Treatment Drug Players Market Share in 2022
    • 3.2.3 Top 6 Invasive Candidiasis Treatment Drug Players Market Share in 2022
  • 3.3 Invasive Candidiasis Treatment Drug Market: Overall Company Footprint Analysis
    • 3.3.1 Invasive Candidiasis Treatment Drug Market: Region Footprint
    • 3.3.2 Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
    • 3.3.3 Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Invasive Candidiasis Treatment Drug Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
  • 6.2 North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
  • 6.3 North America Invasive Candidiasis Treatment Drug Market Size by Country
    • 6.3.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
    • 6.3.2 United States Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
  • 7.2 Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
  • 7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Country
    • 7.3.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 7.3.3 France Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region
    • 8.3.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2029)
    • 8.3.2 China Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 8.3.5 India Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
  • 9.2 South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
  • 9.3 South America Invasive Candidiasis Treatment Drug Market Size by Country
    • 9.3.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country
    • 10.3.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Invasive Candidiasis Treatment Drug Market Drivers
  • 11.2 Invasive Candidiasis Treatment Drug Market Restraints
  • 11.3 Invasive Candidiasis Treatment Drug Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Invasive Candidiasis Treatment Drug Industry Chain
  • 12.2 Invasive Candidiasis Treatment Drug Upstream Analysis
  • 12.3 Invasive Candidiasis Treatment Drug Midstream Analysis
  • 12.4 Invasive Candidiasis Treatment Drug Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Invasive Candidiasis Treatment Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Invasive Candidiasis Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Invasive Candidiasis Treatment Drug market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Invasive Candidiasis Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Invasive Candidiasis Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Invasive Candidiasis Treatment Drug market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Invasive Candidiasis Treatment Drug
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Invasive Candidiasis Treatment Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc and Astellas Pharma Inc, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Invasive Candidiasis Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Azoles Drug
    Echinocandins Drug
    Allylamines Drug
    Polyenes Drug
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Market segment by players, this report covers
    GlaxoSmithKline
    Merck & Co., Inc
    Pfizer Inc
    Cidara Therapeutics, Inc
    Astellas Pharma Inc
    Gilead Sciences, Inc
    Novo Nordisk A/S (Xellia Pharmaceuticals)
    Biosergen AB
    Matinas BioPharma Holdings, Inc
    Pulmocide Ltd
    F2G Ltd
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Invasive Candidiasis Treatment Drug product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Invasive Candidiasis Treatment Drug, with revenue, gross margin and global market share of Invasive Candidiasis Treatment Drug from 2018 to 2023.
    Chapter 3, the Invasive Candidiasis Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Invasive Candidiasis Treatment Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Invasive Candidiasis Treatment Drug.
    Chapter 13, to describe Invasive Candidiasis Treatment Drug research findings and conclusion.

    Buy now